Research Paper | Anaesthesiology | India | Volume 9 Issue 5, May 2020
Pre Emptive Analgesia: A New Dimension in Pain Management
Dr Chandrasekhar Krishnamurti, Dr Mounika Jonnavittula
Nociceptor activation is mediated by chemicals that are released in response to cellular or tissue damage, leading to an intensification of acute pain and even long-term postoperative pain, referred to as central sensitization. Chronic postsurgical pain (CPSP) seen in 10 to 50 % of post surgical patients persists for 36 months after surgery and disrupts their quality of life. Pre-emptive analgesia (PEA) involves the introduction of an analgesic regimen before the onset of noxious stimuli, (not after surgical incision). This prevents this central sensitization and chronic neuropathic syndromes. Treatment strategies involve short and long term techniques started preoperatively and given for an increased duration in the postoperative period to decrease postoperative pain and reducing analgesic consumption in the postoperative period. Preemptive analgesia involves delivery of analgesic therapy that precedes, adequately blocks, and out-lasts the nociceptive stimuli that accompany tissue injury in order to prevent the peripheral and central sensitization that occurs in response to painful stimuli, while leaving physiological pain responses intact. This allows for a more rapid recovery and earlier discharge from hospital.
Keywords: Pre emptive, analgesia
Edition: Volume 9 Issue 5, May 2020
Pages: 1566 - 1572
How to Cite this Article?
Dr Chandrasekhar Krishnamurti, Dr Mounika Jonnavittula, "Pre Emptive Analgesia: A New Dimension in Pain Management", International Journal of Science and Research (IJSR), https://www.ijsr.net/search_index_results_paperid.php?id=SR20507120104, Volume 9 Issue 5, May 2020, 1566 - 1572
34 PDF Views | 31 PDF Downloads
Similar Articles with Keyword 'analgesia'
Research Paper, Anaesthesiology, India, Volume 9 Issue 8, August 2020
Pages: 1422 - 1426A Randomized Double Blind Controlled Interventional Study of Intrathecal Ropivacaine (0.75%) Alone or Ropivacaine (0.75%) with Fentanyl as Adjuvant in Lower Limb Surgeries under Spinal Anaesthesia
Dr Kanchan Chauhan, Dr Satyendra Pancholi, Dr Amit Mangal
Research Paper, Anaesthesiology, India, Volume 9 Issue 8, August 2020
Pages: 1193 - 1197Comparison of Intrathecal Buprenorphine and Dexmedetomidine as an Adjuvant to Bupivacaine Heavy for Post-Operative Analgesia in Patients Undergoing Caesarean Section
Dr. Archana Vaghela, Dr. Jaimin Patel, Dr. Bhavana Soni
Research Paper, Anaesthesiology, India, Volume 9 Issue 5, May 2020
Pages: 1566 - 1572Pre Emptive Analgesia: A New Dimension in Pain Management
Dr Chandrasekhar Krishnamurti, Dr Mounika Jonnavittula
Research Paper, Anaesthesiology, India, Volume 9 Issue 1, January 2020
Pages: 1274 - 1276Comparing the Efficacy of Epidural Buprenorphine versus Epidural Butorphanol in Postoperative Pain Relief in Laparoscopic Surgeries: A Randomized Double Blinded Controlled Study
Dr. P. Gayatri, Dr. B. Sowbhagya Lakshmi
Research Paper, Anaesthesiology, India, Volume 9 Issue 1, January 2020
Pages: 1854 - 1858A Comparative Study of Adjuvants (Dexmedetomidine Vs Dexamethasone) to Ropivacaine in Supraclavicular Brachial Plexus Block for Onset and Duration of Sensory Analgesia
Dr. N. Praneetha, Dr. M. V. Rama Rao